These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22738395)

  • 61. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis.
    Choo MS; Kim M; Ku JH; Kwak C; Kim HH; Jeong CW
    Ann Surg Oncol; 2017 Jul; 24(7):2047-2054. PubMed ID: 28271172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Robot-assisted laparoscopic nerve-sparing radical cystoprostatectomy with bilateral extended lymph node dissection and intracorporeal studer pouch construction: outcomes of first 12 cases.
    Akbulut Z; Canda AE; Ozcan MF; Atmaca AF; Ozdemir AT; Balbay MD
    J Endourol; 2011 Sep; 25(9):1469-79. PubMed ID: 21830910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy.
    Gandaglia G; Gallina A; Suardi N; Abdollah F; Passoni N; Bianchi M; Zaffuto E; Nini A; Vizziello D; Salonia A; Montorsi F; Briganti A
    Int J Impot Res; 2014; 26(6):201-4. PubMed ID: 24784890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of a hyaluronic acid-carboxymethylcellulose adhesion barrier on the neurovascular bundle and prostatic bed to facilitate earlier recovery of erectile function after robot-assisted prostatectomy: an initial experience.
    Joung JY; Ha YS; Singer EA; Ercolani MC; Favaretto RL; Lee DH; Kim WJ; Lee KH; Kim IY
    J Endourol; 2013 Oct; 27(10):1230-5. PubMed ID: 23879531
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
    Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
    Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative and qualitative analysis of the recovery of potency after radical prostatectomy: effect of unilateral vs bilateral nerve sparing.
    Finley DS; Rodriguez E; Skarecky DW; Ahlering TE
    BJU Int; 2009 Nov; 104(10):1484-9. PubMed ID: 19388985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retrospective Concomitant Nonrandomized Comparison of "Touch" Cautery Versus Athermal Dissection of the Prostatic Vascular Pedicles and Neurovascular Bundles During Robot-assisted Radical Prostatectomy.
    Hofmann M; Huang E; Huynh LM; Kaler K; Vernez S; Gordon A; Morales B; Skarecky D; Ahlering TE
    Eur Urol; 2022 Jan; 81(1):104-109. PubMed ID: 34384621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impacting factors for recovery of erectile function within 1 year following robotic-assisted laparoscopic radical prostatectomy.
    Ko WJ; Truesdale MD; Hruby GW; Landman J; Badani KK
    J Sex Med; 2011 Jun; 8(6):1805-12. PubMed ID: 21426493
    [TBL] [Abstract][Full Text] [Related]  

  • 72. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.
    Stolzenburg JU; Graefen M; Kriegel C; Michl U; Martin Morales A; Pommerville PJ; Manning M; Büttner H; Henneges C; Schostak M
    BJU Int; 2015 Aug; 116(2):241-51. PubMed ID: 25560809
    [TBL] [Abstract][Full Text] [Related]  

  • 74. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy.
    Schifano N; Capogrosso P; Pozzi E; Ventimiglia E; Cazzaniga W; Matloob R; Gandaglia G; Dehò F; Briganti A; Montorsi F; Salonia A
    Andrology; 2020 Mar; 8(2):337-341. PubMed ID: 31478610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.
    Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI
    Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy.
    Salonia A; Zanni G; Gallina A; Saccà A; Sangalli M; Naspro R; Briganti A; Farina E; Roscigno M; Dapozzo LF; Rigatti P; Montorsi F
    Eur Urol; 2006 Aug; 50(2):360-5. PubMed ID: 16413666
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.
    Tomisaki I; Ikuta H; Higashijima K; Onishi R; Minato A; Fujimoto N
    Cancer Invest; 2019; 37(10):524-530. PubMed ID: 31597501
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.
    Bianchi L; Gandaglia G; Fossati N; Suardi N; Moschini M; Cucchiara V; Bianchi M; Damiano R; Schiavina R; Shariat SF; Montorsi F; Briganti A
    Urologia; 2017 Feb; 84(1):9-19. PubMed ID: 26689534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
    Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
    Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.